Lithium Carbonate vs Pembrolizumab

## Lithium Carbonate vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Lithium Carbonate** and **Pembrolizumab**.

## Mechanism of Action

**Lithium Carbonate**: Modulates intracellular signaling via inositol and GSK-3 inhibition.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Lithium Carbonate — 18-36 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Lithium Carbonate — Li2CO3; Pembrolizumab — N/A.

**Molecular Weight**: Lithium Carbonate — 73.8910 g/mol; Pembrolizumab — N/A.

**Type**: Lithium Carbonate — Small molecule; Pembrolizumab — Antibody.